214 related articles for article (PubMed ID: 21097718)
1. Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing.
Zang ZJ; Ong CK; Cutcutache I; Yu W; Zhang SL; Huang D; Ler LD; Dykema K; Gan A; Tao J; Lim S; Liu Y; Futreal PA; Grabsch H; Furge KA; Goh LK; Rozen S; Teh BT; Tan P
Cancer Res; 2011 Jan; 71(1):29-39. PubMed ID: 21097718
[TBL] [Abstract][Full Text] [Related]
2. Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer.
Kubo T; Kuroda Y; Shimizu H; Kokubu A; Okada N; Hosoda F; Arai Y; Nakamura Y; Taniguchi H; Yanagihara K; Imoto I; Inazawa J; Hirohashi S; Shibata T
Carcinogenesis; 2009 Nov; 30(11):1857-64. PubMed ID: 19734198
[TBL] [Abstract][Full Text] [Related]
3. Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion.
Asaoka Y; Tada M; Ikenoue T; Seto M; Imai M; Miyabayashi K; Yamamoto K; Yamamoto S; Kudo Y; Mohri D; Isomura Y; Ijichi H; Tateishi K; Kanai F; Ogawa S; Omata M; Koike K
Biochem Biophys Res Commun; 2010 Apr; 394(4):1042-6. PubMed ID: 20331976
[TBL] [Abstract][Full Text] [Related]
4. Truncation- and motif-based pan-cancer analysis reveals tumor-suppressing kinases.
Hudson AM; Stephenson NL; Li C; Trotter E; Fletcher AJ; Katona G; Bieniasz-Krzywiec P; Howell M; Wirth C; Furney S; Miller CJ; Brognard J
Sci Signal; 2018 Apr; 11(526):. PubMed ID: 29666306
[TBL] [Abstract][Full Text] [Related]
5. Role of germline aberrations affecting
Weren RDA; van der Post RS; Vogelaar IP; van Krieken JH; Spruijt L; Lubinski J; Jakubowska A; Teodorczyk U; Aalfs CM; van Hest LP; Oliveira C; Kamping EJ; Schackert HK; Ranzani GN; Gómez García EB; Hes FJ; Holinski-Feder E; Genuardi M; Ausems MGEM; Sijmons RH; Wagner A; van der Kolk LE; Cats A; Bjørnevoll I; Hoogerbrugge N; Ligtenberg MJL
J Med Genet; 2018 Oct; 55(10):669-674. PubMed ID: 29330337
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor structural alterations in gastric cancer.
Moutinho C; Mateus AR; Milanezi F; Carneiro F; Seruca R; Suriano G
BMC Cancer; 2008 Jan; 8():10. PubMed ID: 18199332
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of whole genome exon array and array-comparative genomic hybridization in gastric and colorectal cancer cells.
Furuta K; Arao T; Sakai K; Kimura H; Nagai T; Tamura D; Aomatsu K; Kudo K; Kaneda H; Fujita Y; Matsumoto K; Yamada Y; Yanagihara K; Sekijima M; Nishio K
Cancer Sci; 2012 Feb; 103(2):221-7. PubMed ID: 22034905
[TBL] [Abstract][Full Text] [Related]
8. Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.
Ali SM; Sanford EM; Klempner SJ; Rubinson DA; Wang K; Palma NA; Chmielecki J; Yelensky R; Palmer GA; Morosini D; Lipson D; Catenacci DV; Braiteh F; Erlich R; Stephens PJ; Ross JS; Ou SH; Miller VA
Oncologist; 2015 May; 20(5):499-507. PubMed ID: 25882375
[TBL] [Abstract][Full Text] [Related]
9. Large-scale proteomics analysis of the human kinome.
Oppermann FS; Gnad F; Olsen JV; Hornberger R; Greff Z; Kéri G; Mann M; Daub H
Mol Cell Proteomics; 2009 Jul; 8(7):1751-64. PubMed ID: 19369195
[TBL] [Abstract][Full Text] [Related]
10. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
[TBL] [Abstract][Full Text] [Related]
11. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways.
Yu ZY; Jiang XY; Zhao RR; Qin JJ; Luo CJ; Ren YX; Ren W; Ma ZJ; Jiao ZY
Chin Med J (Engl); 2020 Apr; 133(8):919-928. PubMed ID: 32187050
[TBL] [Abstract][Full Text] [Related]
12. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
Aigner A; Juhl H; Malerczyk C; Tkybusch A; Benz CC; Czubayko F
Oncogene; 2001 Apr; 20(17):2101-11. PubMed ID: 11360194
[TBL] [Abstract][Full Text] [Related]
13. Protein-tyrosine kinase and protein-serine/threonine kinase expression in human gastric cancer cell lines.
Lin JS; Lu CW; Huang CJ; Wu PF; Robinson D; Kung HJ; Chi CW; Wu CW; Yang WK; Whang-Peng JJ; Lin WC
J Biomed Sci; 1998; 5(2):101-10. PubMed ID: 9662069
[TBL] [Abstract][Full Text] [Related]
14. A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth.
Mita H; Toyota M; Aoki F; Akashi H; Maruyama R; Sasaki Y; Suzuki H; Idogawa M; Kashima L; Yanagihara K; Fujita M; Hosokawa M; Kusano M; Sabau SV; Tatsumi H; Imai K; Shinomura Y; Tokino T
BMC Cancer; 2009 Jun; 9():198. PubMed ID: 19545448
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities.
Millis SZ; Jardim DL; Albacker L; Ross JS; Miller VA; Ali SM; Kurzrock R
Cancer; 2019 Apr; 125(7):1185-1199. PubMed ID: 30582752
[TBL] [Abstract][Full Text] [Related]
16. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
17. Reduced phosphorylation of ribosomal protein S6 is associated with sensitivity to MEK inhibition in gastric cancer cells.
Hirashita Y; Tsukamoto Y; Yanagihara K; Fumoto S; Hijiya N; Nakada C; Uchida T; Matsuura K; Kodama M; Okimoto T; Daa T; Seike M; Iha H; Shirao K; Murakami K; Moriyama M
Cancer Sci; 2016 Dec; 107(12):1919-1928. PubMed ID: 27699948
[TBL] [Abstract][Full Text] [Related]
18. Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.
Park H; Cho SY; Kim H; Na D; Han JY; Chae J; Park C; Park OK; Min S; Kang J; Choi B; Min J; Kwon JY; Suh YS; Kong SH; Lee HJ; Liu ET; Kim JI; Kim S; Yang HK; Lee C
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12492-7. PubMed ID: 26401016
[TBL] [Abstract][Full Text] [Related]
19.
Xu C; Ooi WF; Qamra A; Tan J; Chua BY; Ho SWT; Das K; Adam Isa ZF; Li Z; Yao X; Yan T; Xing M; Huang KK; Lin JS; Nandi T; Tay ST; Lee MH; Tan ALK; Ong X; Ashktorab H; Smoot D; Li S; Ng SC; Teh BT; Tan P
Gut; 2020 Feb; 69(2):231-242. PubMed ID: 31068366
[TBL] [Abstract][Full Text] [Related]
20. Prolonged MEK inhibition leads to acquired resistance and increased invasiveness in KRAS mutant gastric cancer.
Choi KM; Cho E; Kim E; Shin JH; Kang M; Kim B; Han EH; Chung YH; Kim JY
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):311-318. PubMed ID: 30466782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
